Filter Results
:
(506)
Show Results For
-
All HBS Web
(506)
- People (2)
- News (133)
- Research (126)
- Events (2)
- Multimedia (5)
- Faculty Publications (68)
Show Results For
-
All HBS Web
(506)
- People (2)
- News (133)
- Research (126)
- Events (2)
- Multimedia (5)
- Faculty Publications (68)
- 01 Sep 2012
- News
High Honors
companies, primarily in the computer and health-care realm. In the four decades since, Johnson has helped build the biotech industry and earned a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. Among his...
View Details
- 12 Jul 2021
- News
Alumni Confront the COVID-19 Crisis
PYMNTS.com. (Readers who know of groups in need of PPE can email Miller at anne@projectn95.org.) NOVEMBER 23 Cambridge-based biotech Moderna, led by CEO Stephane Bancel (MBA 2000, AMP 170), released promising results on the coronavirus...
View Details
- Web
Annual Report 2017 - Annual Report 2017
press release Pagliuca Harvard Life Lab The newest addition to the Harvard Innovation Lab (i-lab) ecosystem, the Life Lab—made possible by a gift from Judy (MBA 1983) and Steve (MBA 1982) Pagliuca—offers shared space for high-potential life sciences and View Details
- 01 Dec 2004
- News
The Future of Stem Cells
year for research on existing lines, even as other countries are investing many times that amount. Says Cynthia Fisher (MBA ’90), president and CEO of BioMed 20/20 Technologies, a biotech and medical information products firm, “The...
View Details
Keywords:
Garry Emmons
- 07 Feb 2017
- First Look
First Look at New Research: February 7
case:https://cb.hbsp.harvard.edu/cbmp/product/517027-PDF-ENG Harvard Business School Case 617-022 Alnylam Pharmaceuticals: Building Value from the IP Estate (B) The leader of a pioneering biotech company in the siRNA space weighs his...
View Details
Keywords:
Sean Silverthorne
- 03 May 2011
- First Look
First Look: May 3
Business Model Gary P. Pisano, Ryan Johnson, and Carin-Isabel KnoopHarvard Business School Case 611-046 In the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this...
View Details
Keywords:
Sean Silverthorne
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
case:https://hbsp.harvard.edu/product/318082-PDF-ENG Harvard Business School Case 318-083 Sandra Brown Goes Digital (B): The Commitment Decision Sandra Brown, a middle manager at a biotech company who has led internal and external...
View Details
Keywords:
Dina Gerdeman
- 01 Sep 2008
- News
Mara Aspinall
ASPINALL Illustration by Jack Unruh When you ask people about their great fears in life, virtually everyone talks about cancer,” says Mara G. Aspinall (MBA ’87), past president of Genzyme Genetics, a Westborough, Massachusetts-based division of the View Details
- 12 Sep 2006
- First Look
First Look: September 12, 2006
organization's relational capacity. The benefits will reverberate throughout every dimension of the company's work. Financial Contracting in Biotech Strategic Alliances Authors:David T. Robinson and Toby E. Stuart Periodical:Journal of...
View Details
Keywords:
Sean Silverthorne
- 12 May 2009
- First Look
First Look: May 12, 2009
this situation, donations are likely to decline, investment surplus has declined and biotech partners are challenged to finance joint projects as well as their own operations. Beall is striving to find a cure for cystic fibrosis while...
View Details
Keywords:
Martha Lagace
- 01 Sep 2009
- News
E Ink’s Wild Ride
that required a massive amount of investment before it could take off,” says Yoffie, who served on E Ink’s board from 1999 to 2004. “The truism is that getting to that point takes longer and costs more money than the most pessimistic forecast. It’s a very similar...
View Details
- 01 Jun 2007
- News
Mission Possible
“Rudy contends that if we can identify the other ten or twelve genes that are players, we can give the biotech industry so many more shots to come up with a therapy,” explains McCance, who, along with his cofounders, is privately...
View Details
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
technological innovation, which is how the biotechs and some of the medical devices can get through these hurdles. But for a health service innovation, the payment hurdles are so massive it's masochistic. Then if you go into competition...
View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
drug development process; threats from biotech and generics competitors; pharmaceutical manufacturing, selling, and marketing; and pharmaceutical consumption in Europe, the third world, and the U.S. Merck and Pfizer are analyzed in-depth...
View Details
Keywords:
Sean Silverthorne
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
four-and-a-half year period. Problems involved everything from biotech to consumer products and agrochemicals. Thanks to broadcasting, nearly one-third of the previously unsolved problems found successful solutions. "Innovations...
View Details
Keywords:
by Martha Lagace
- Web
Annual Report 2016 - Annual Report 2016
products giant Faber-Castell and ARRI, the world’s largest manufacturer of professional motion picture equipment. Expanding the I-Lab Ecosystem Work begins on the Pagliuca Harvard Life Lab, a new facility that will offer shared space for high-potential life sciences...
View Details
- 01 Sep 2008
- News
Balanced Equation
significantly. However, we remain a service organization helping entrepreneurs with disruptive technologies that create or transform business. KPCB has always focused on biotech and information technologies. Today we’ve added energy...
View Details
- Web
Podcast - Managing the Future of Work
gamut from a PhD all the way to a lab technician. We have contracts with the United States government. We’re working on the vaccine response and tracking. We also provide lab technicians that are working with major pharmaceutical and View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with...
View Details